{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:43:13Z","timestamp":1791726193928,"version":"4.3.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T00:00:00Z","timestamp":1587600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T00:00:00Z","timestamp":1587600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hungarian Academy of Sciences Premium Postdoctoral Research Grant","award":["PPD-003\/2016, group ID 460011"],"award-info":[{"award-number":["PPD-003\/2016, group ID 460011"]}]},{"name":"Hungarian National Research, Development and Innovation Office","award":["NN 114460"],"award-info":[{"award-number":["NN 114460"]}]},{"name":"Hungarian National Research, Development and Innovation Office","award":["K 116340"],"award-info":[{"award-number":["K 116340"]}]},{"name":"Semmelweis University Dean\u2019s Award 2015"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Abstract<\/jats:title><jats:p>This study shows that melanoma-associated fibroblasts (MAFs) suppress cytotoxic T lymphocyte (CTL) activity and reveals a pivotal role played by arginase in this phenomenon. MAFs and normal dermal fibroblasts (DFs) were isolated from surgically resected melanomas and identified as Melan-A-\/gp100-\/FAP+\u2009cells. CTLs of healthy blood donors were activated in the presence of MAF- and DF-conditioned media (CM). Markers of successful CTL activation, cytotoxic degranulation, killing activity and immune checkpoint regulation were evaluated by flow cytometry, ELISPOT, and redirected killing assays. Soluble mediators responsible for MAF-mediated effects were identified by ELISA, flow cytometry, inhibitor assays, and knock-in experiments. In the presence of MAF-CM, activated\/non-na\u00efve CTLs displayed dysregulated ERK1\/2 and NF-\u03baB signaling, impeded CD69 and granzyme B production, impaired killing activity, and upregulated expression of the negative immune checkpoint receptors TIGIT and BTLA. Compared to DFs, MAFs displayed increased amounts of VISTA and HVEM, a known ligand of BTLA on T cells, increased<jats:sc>l<\/jats:sc>-arginase activity and CXCL12 release. Transgenic arginase over-expression further increased, while selective arginase inhibition neutralized MAF-induced TIGIT and BTLA expression on CTLs. Our data indicate that MAF interfere with intracellular CTL signaling via soluble mediators leading to CTL anergy and modify immune checkpoint receptor availability via<jats:sc>l<\/jats:sc>-arginine depletion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Graphic abstract<\/jats:title><\/jats:sec>","DOI":"10.1007\/s00018-020-03517-8","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T07:02:48Z","timestamp":1587625368000},"page":"661-673","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Melanoma-associated fibroblasts impair CD8+\u2009T cell function and modify expression of immune checkpoint regulators via increased arginase activity"],"prefix":"10.1007","volume":"78","author":[{"given":"Barbara","family":"\u00c9rsek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e1lma","family":"Sill\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugur","family":"Cakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Moln\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s","family":"Bencsik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Mezey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarolta","family":"K\u00e1rp\u00e1ti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2574-7616","authenticated-orcid":false,"given":"Zolt\u00e1n","family":"P\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kriszti\u00e1n","family":"N\u00e9meth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,23]]},"reference":[{"issue":"9","key":"3517_CR1","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R (2016) The biology and function of fibroblasts in cancer. Nat Rev Cancer 16(9):582\u2013598. https:\/\/doi.org\/10.1038\/nrc.2016.73","journal-title":"Nat Rev Cancer"},{"key":"3517_CR2","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3389\/fimmu.2018.00414","volume":"9","author":"L Ziani","year":"2018","unstructured":"Ziani L, Chouaib S, Thiery J (2018) Alteration of the antitumor immune response by cancer-associated fibroblasts. Front Immunol 9:414. https:\/\/doi.org\/10.3389\/fimmu.2018.00414","journal-title":"Front Immunol"},{"issue":"4","key":"3517_CR3","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.3390\/cancers7040902","volume":"7","author":"K Shiga","year":"2015","unstructured":"Shiga K, Hara M, Nagasaki T, Sato T, Takahashi H, Takeyama H (2015) Cancer-associated fibroblasts: their characteristics and their roles in tumor growth. Cancers (Basel) 7(4):2443\u20132458. https:\/\/doi.org\/10.3390\/cancers7040902","journal-title":"Cancers (Basel)"},{"issue":"6005","key":"3517_CR4","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1126\/science.1195300","volume":"330","author":"M Kraman","year":"2010","unstructured":"Kraman M, Bambrough PJ, Arnold JN, Roberts EW, Magiera L, Jones JO, Gopinathan A, Tuveson DA, Fearon DT (2010) Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. Science 330(6005):827\u2013830. https:\/\/doi.org\/10.1126\/science.1195300","journal-title":"Science"},{"issue":"50","key":"3517_CR5","doi-asserted-by":"publisher","first-page":"20212","DOI":"10.1073\/pnas.1320318110","volume":"110","author":"C Feig","year":"2013","unstructured":"Feig C, Jones JO, Kraman M, Wells RJ, Deonarine A, Chan DS, Connell CM, Roberts EW, Zhao Q, Caballero OL, Teichmann SA, Janowitz T, Jodrell DI, Tuveson DA, Fearon DT (2013) Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. Proc Natl Acad Sci U S A 110(50):20212\u201320217. https:\/\/doi.org\/10.1073\/pnas.1320318110","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3517_CR6","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1158\/2326-6066.CIR-13-0027","volume":"2","author":"LC Wang","year":"2014","unstructured":"Wang LC, Lo A, Scholler J, Sun J, Majumdar RS, Kapoor V, Antzis M, Cotner CE, Johnson LA, Durham AC, Solomides CC, June CH, Pure E, Albelda SM (2014) Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity. Cancer Immunol Res 2(2):154\u2013166. https:\/\/doi.org\/10.1158\/2326-6066.CIR-13-0027","journal-title":"Cancer Immunol Res"},{"issue":"17","key":"3517_CR7","doi-asserted-by":"publisher","first-page":"23282","DOI":"10.18632\/oncotarget.7818","volume":"7","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Ertl HC (2016) Depletion of FAP+ cells reduces immunosuppressive cells and improves metabolism and functions CD8+T cells within tumors. Oncotarget 7(17):23282\u201323299. https:\/\/doi.org\/10.18632\/oncotarget.7818","journal-title":"Oncotarget"},{"issue":"49","key":"3517_CR8","doi-asserted-by":"publisher","first-page":"20847","DOI":"10.1073\/pnas.0906481106","volume":"106","author":"M Balsamo","year":"2009","unstructured":"Balsamo M, Scordamaglia F, Pietra G, Manzini C, Cantoni C, Boitano M, Queirolo P, Vermi W, Facchetti F, Moretta A, Moretta L, Mingari MC, Vitale M (2009) Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity. Proc Natl Acad Sci U S A 106(49):20847\u201320852. https:\/\/doi.org\/10.1073\/pnas.0906481106","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"3517_CR9","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1158\/0008-5472.CAN-11-2544","volume":"72","author":"G Pietra","year":"2012","unstructured":"Pietra G, Manzini C, Rivara S, Vitale M, Cantoni C, Petretto A, Balsamo M, Conte R, Benelli R, Minghelli S, Solari N, Gualco M, Queirolo P, Moretta L, Mingari MC (2012) Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity. Cancer Res 72(6):1407\u20131415. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-2544","journal-title":"Cancer Res"},{"issue":"12","key":"3517_CR10","doi-asserted-by":"publisher","first-page":"19780","DOI":"10.18632\/oncotarget.15540","volume":"8","author":"L Ziani","year":"2017","unstructured":"Ziani L, Safta-Saadoun TB, Gourbeix J, Cavalcanti A, Robert C, Favre G, Chouaib S, Thiery J (2017) Melanoma-associated fibroblasts decrease tumor cell susceptibility to NK cell-mediated killing through matrix-metalloproteinases secretion. Oncotarget 8(12):19780\u201319794. https:\/\/doi.org\/10.18632\/oncotarget.15540","journal-title":"Oncotarget"},{"issue":"11","key":"3517_CR11","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00262-011-1064-9","volume":"60","author":"D Holt","year":"2011","unstructured":"Holt D, Ma X, Kundu N, Fulton A (2011) Prostaglandin E(2) (PGE (2)) suppresses natural killer cell function primarily through the PGE(2) receptor EP4. Cancer Immunol Immunother 60(11):1577\u20131586. https:\/\/doi.org\/10.1007\/s00262-011-1064-9","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"3517_CR12","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.3892\/ijo.2016.3631","volume":"49","author":"T Inoue","year":"2016","unstructured":"Inoue T, Adachi K, Kawana K, Taguchi A, Nagamatsu T, Fujimoto A, Tomio K, Yamashita A, Eguchi S, Nishida H, Nakamura H, Sato M, Yoshida M, Arimoto T, Wada-Hiraike O, Oda K, Osuga Y, Fujii T (2016) Cancer-associated fibroblast suppresses killing activity of natural killer cells through downregulation of poliovirus receptor (PVR\/CD155), a ligand of activating NK receptor. Int J Oncol 49(4):1297\u20131304. https:\/\/doi.org\/10.3892\/ijo.2016.3631","journal-title":"Int J Oncol"},{"issue":"4","key":"3517_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nm.3831","volume":"21","author":"JH Chen","year":"2015","unstructured":"Chen JH, Perry CJ, Tsui YC, Staron MM, Parish IA, Dominguez CX, Rosenberg DW, Kaech SM (2015) Prostaglandin E2 and programmed cell death 1 signaling coordinately impair CTL function and survival during chronic viral infection. Nat Med 21(4):327\u2013334. https:\/\/doi.org\/10.1038\/nm.3831","journal-title":"Nat Med"},{"issue":"1","key":"3517_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1158\/1535-7163.MCT-16-0333-T","volume":"16","author":"A Furedi","year":"2017","unstructured":"Furedi A, Toth S, Szebenyi K, Pape VF, Turk D, Kucsma N, Cervenak L, Tovari J, Szakacs G (2017) Identification and validation of compounds selectively killing resistant cancer: delineating cell line-specific effects from p-glycoprotein-induced toxicity. Mol Cancer Ther 16(1):45\u201356. https:\/\/doi.org\/10.1158\/1535-7163.MCT-16-0333-T","journal-title":"Mol Cancer Ther"},{"issue":"11","key":"3517_CR15","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1681\/ASN.2014070705","volume":"26","author":"K Szebenyi","year":"2015","unstructured":"Szebenyi K, Furedi A, Kolacsek O, Csohany R, Prokai A, Kis-Petik K, Szabo A, Bosze Z, Bender B, Tovari J, Enyedi A, Orban TI, Apati A, Sarkadi B (2015) Visualization of calcium dynamics in kidney proximal tubules. J Am Soc Nephrol 26(11):2731\u20132740. https:\/\/doi.org\/10.1681\/ASN.2014070705","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"3517_CR16","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1586\/erv.10.49","volume":"9","author":"L Zaritskaya","year":"2010","unstructured":"Zaritskaya L, Shurin MR, Sayers TJ, Malyguine AM (2010) New flow cytometric assays for monitoring cell-mediated cytotoxicity. Expert Rev Vaccines 9(6):601\u2013616. https:\/\/doi.org\/10.1586\/erv.10.49","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"3517_CR17","doi-asserted-by":"crossref","first-page":"651","DOI":"10.4049\/jimmunol.162.2.651","volume":"162","author":"D Saverino","year":"1999","unstructured":"Saverino D, Tenca C, Zarcone D, Merlo A, Megiovanni AM, Valle MT, Manca F, Grossi CE, Ciccone E (1999) CTLA-4 (CD152) inhibits the specific lysis mediated by human cytolytic T lymphocytes in a clonally distributed fashion. J Immunol 162(2):651\u2013658","journal-title":"J Immunol"},{"issue":"12","key":"3517_CR18","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1182\/blood-2011-02-336321","volume":"118","author":"A Pievani","year":"2011","unstructured":"Pievani A, Borleri G, Pende D, Moretta L, Rambaldi A, Golay J, Introna M (2011) Dual-functional capability of CD3+ CD56+ CIK cells, a T cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity. Blood 118(12):3301\u20133310. https:\/\/doi.org\/10.1182\/blood-2011-02-336321","journal-title":"Blood"},{"issue":"8","key":"3517_CR19","doi-asserted-by":"publisher","first-page":"1599635","DOI":"10.1080\/2162402X.2019.1599635","volume":"8","author":"N Nelson","year":"2019","unstructured":"Nelson N, Lopez-Pelaez M, Palazon A, Poon E, De La Roche M, Barry S, Valge-Archer V, Wilkinson RW, Dovedi SJ, Smith PD (2019) A cell-engineered system to assess tumor cell sensitivity to CD8(+) T cell-mediated cytotoxicity. Oncoimmunology 8(8):1599635. https:\/\/doi.org\/10.1080\/2162402X.2019.1599635","journal-title":"Oncoimmunology"},{"issue":"10","key":"3517_CR20","doi-asserted-by":"publisher","first-page":"5931","DOI":"10.4049\/jimmunol.172.10.5931","volume":"172","author":"P Han","year":"2004","unstructured":"Han P, Goularte OD, Rufner K, Wilkinson B, Kaye J (2004) An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection. J Immunol 172(10):5931\u20135939","journal-title":"J Immunol"},{"issue":"3","key":"3517_CR21","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.jaci.2017.11.050","volume":"142","author":"S Ghosh","year":"2018","unstructured":"Ghosh S, Carmo M, Calero-Garcia M, Ricciardelli I, Bustamante Ogando JC, Blundell MP, Schambach A, Ashton-Rickardt PG, Booth C, Ehl S, Lehmberg K, Thrasher AJ, Gaspar HB (2018) T cell gene therapy for perforin deficiency corrects cytotoxicity defects and prevents hemophagocytic lymphohistiocytosis manifestations. J Allergy Clin Immunol 142(3):904\u2013913. https:\/\/doi.org\/10.1016\/j.jaci.2017.11.050","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"3517_CR22","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.4049\/jimmunol.174.5.2653","volume":"174","author":"A Poggi","year":"2005","unstructured":"Poggi A, Massaro AM, Negrini S, Contini P, Zocchi MR (2005) Tumor-induced apoptosis of human IL-2-activated NK cells: role of natural cytotoxicity receptors. J Immunol 174(5):2653\u20132660. https:\/\/doi.org\/10.4049\/jimmunol.174.5.2653","journal-title":"J Immunol"},{"issue":"2","key":"3517_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/ijc.20388","volume":"112","author":"IF San Francisco","year":"2004","unstructured":"San Francisco IF, DeWolf WC, Peehl DM, Olumi AF (2004) Expression of transforming growth factor-beta 1 and growth in soft agar differentiate prostate carcinoma-associated fibroblasts from normal prostate fibroblasts. Int J Cancer 112(2):213\u2013218. https:\/\/doi.org\/10.1002\/ijc.20388","journal-title":"Int J Cancer"},{"issue":"2","key":"3517_CR24","doi-asserted-by":"publisher","first-page":"e55146","DOI":"10.1371\/journal.pone.0055146","volume":"8","author":"Y Ino","year":"2013","unstructured":"Ino Y, Yamazaki-Itoh R, Oguro S, Shimada K, Kosuge T, Zavada J, Kanai Y, Hiraoka N (2013) Arginase II expressed in cancer-associated fibroblasts indicates tissue hypoxia and predicts poor outcome in patients with pancreatic cancer. PLoS ONE 8(2):e55146. https:\/\/doi.org\/10.1371\/journal.pone.0055146","journal-title":"PLoS ONE"},{"issue":"4","key":"3517_CR25","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s13058-014-0410-1","volume":"16","author":"JY Chen","year":"2014","unstructured":"Chen JY, Li CF, Kuo CC, Tsai KK, Hou MF, Hung WC (2014) Cancer\/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression. Breast Cancer Res 16(4):410. https:\/\/doi.org\/10.1186\/s13058-014-0410-1","journal-title":"Breast Cancer Res"},{"issue":"2","key":"3517_CR26","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1152\/physrev.00037.2016","volume":"98","author":"RW Caldwell","year":"2018","unstructured":"Caldwell RW, Rodriguez PC, Toque HA, Narayanan SP, Caldwell RB (2018) Arginase: a multifaceted enzyme important in health and disease. Physiol Rev 98(2):641\u2013665. https:\/\/doi.org\/10.1152\/physrev.00037.2016","journal-title":"Physiol Rev"},{"issue":"3","key":"3517_CR27","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","volume":"121","author":"A Orimo","year":"2005","unstructured":"Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion. Cell 121(3):335\u2013348. https:\/\/doi.org\/10.1016\/j.cell.2005.02.034","journal-title":"Cell"},{"issue":"1","key":"3517_CR28","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s40425-019-0675-0","volume":"7","author":"PF Wong","year":"2019","unstructured":"Wong PF, Wei W, Gupta S, Smithy JW, Zelterman D, Kluger HM, Rimm DL (2019) Multiplex quantitative analysis of cancer-associated fibroblasts and immunotherapy outcome in metastatic melanoma. J Immunother Cancer 7(1):194. https:\/\/doi.org\/10.1186\/s40425-019-0675-0","journal-title":"J Immunother Cancer"},{"issue":"1","key":"3517_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bbrc.2017.03.039","volume":"487","author":"L Chen","year":"2017","unstructured":"Chen L, Qiu X, Wang X, He J (2017) FAP positive fibroblasts induce immune checkpoint blockade resistance in colorectal cancer via promoting immunosuppression. Biochem Biophys Res Commun 487(1):8\u201314. https:\/\/doi.org\/10.1016\/j.bbrc.2017.03.039","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"3517_CR30","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s40425-019-0719-5","volume":"7","author":"B Mastelic-Gavillet","year":"2019","unstructured":"Mastelic-Gavillet B, Navarro Rodrigo B, Decombaz L, Wang H, Ercolano G, Ahmed R, Lozano LE, Ianaro A, Derre L, Valerio M, Tawadros T, Jichlinski P, Nguyen-Ngoc T, Speiser DE, Verdeil G, Gestermann N, Dormond O, Kandalaft L, Coukos G, Jandus C, Menetrier-Caux C, Caux C, Ho PC, Romero P, Harari A, Vigano S (2019) Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8(+) T cells. J Immunother Cancer 7(1):257. https:\/\/doi.org\/10.1186\/s40425-019-0719-5","journal-title":"J Immunother Cancer"},{"issue":"8","key":"3517_CR31","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.4049\/jimmunol.1103627","volume":"188","author":"E Lozano","year":"2012","unstructured":"Lozano E, Dominguez-Villar M, Kuchroo V, Hafler DA (2012) The TIGIT\/CD226 axis regulates human T cell function. J Immunol 188(8):3869\u20133875. https:\/\/doi.org\/10.4049\/jimmunol.1103627","journal-title":"J Immunol"},{"issue":"5795","key":"3517_CR32","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1126\/science.1129139","volume":"313","author":"J Galon","year":"2006","unstructured":"Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoue F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pages F (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313(5795):1960\u20131964. https:\/\/doi.org\/10.1126\/science.1129139","journal-title":"Science"},{"issue":"5","key":"3517_CR33","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.3892\/or.2013.2302","volume":"29","author":"K Wakatsuki","year":"2013","unstructured":"Wakatsuki K, Sho M, Yamato I, Takayama T, Matsumoto S, Tanaka T, Migita K, Ito M, Hotta K, Nakajima Y (2013) Clinical impact of tumor-infiltrating CD45RO(+) memory T cells on human gastric cancer. Oncol Rep 29(5):1756\u20131762. https:\/\/doi.org\/10.3892\/or.2013.2302","journal-title":"Oncol Rep"},{"issue":"2","key":"3517_CR34","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1365-2249.2012.04565.x","volume":"168","author":"K Enomoto","year":"2012","unstructured":"Enomoto K, Sho M, Wakatsuki K, Takayama T, Matsumoto S, Nakamura S, Akahori T, Tanaka T, Migita K, Ito M, Nakajima Y (2012) Prognostic importance of tumour-infiltrating memory T cells in oesophageal squamous cell carcinoma. Clin Exp Immunol 168(2):186\u2013191. https:\/\/doi.org\/10.1111\/j.1365-2249.2012.04565.x","journal-title":"Clin Exp Immunol"},{"key":"3517_CR35","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ejca.2016.12.031","volume":"75","author":"JK Tietze","year":"2017","unstructured":"Tietze JK, Angelova D, Heppt MV, Reinholz M, Murphy WJ, Spannagl M, Ruzicka T, Berking C (2017) The proportion of circulating CD45RO(+) CD8(+) memory T cells is correlated with clinical response in melanoma patients treated with ipilimumab. Eur J Cancer 75:268\u2013279. https:\/\/doi.org\/10.1016\/j.ejca.2016.12.031","journal-title":"Eur J Cancer"},{"key":"3517_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejca.2016.12.011","volume":"73","author":"K Wistuba-Hamprecht","year":"2017","unstructured":"Wistuba-Hamprecht K, Martens A, Heubach F, Romano E, Geukes Foppen M, Yuan J, Postow M, Wong P, Mallardo D, Schilling B, Di Giacomo AM, Khammari A, Dreno B, Maio M, Schadendorf D, Ascierto PA, Wolchok JD, Blank CU, Garbe C, Pawelec G, Weide B (2017) Peripheral CD8 effector-memory type 1 T cells correlate with outcome in ipilimumab-treated stage IV melanoma patients. Eur J Cancer 73:61\u201370. https:\/\/doi.org\/10.1016\/j.ejca.2016.12.011","journal-title":"Eur J Cancer"},{"issue":"10","key":"3517_CR37","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1111\/cas.13758","volume":"109","author":"K Yamaguchi","year":"2018","unstructured":"Yamaguchi K, Mishima K, Ohmura H, Hanamura F, Ito M, Nakano M, Tsuchihashi K, Ota SI, Wada N, Uchi H, Ariyama H, Kusaba H, Niiro H, Akashi K, Baba E (2018) Activation of central\/effector memory T cells and T-helper 1 polarization in malignant melanoma patients treated with anti-programmed death-1 antibody. Cancer Sci 109(10):3032\u20133042. https:\/\/doi.org\/10.1111\/cas.13758","journal-title":"Cancer Sci"},{"issue":"3","key":"3517_CR38","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1158\/2326-6066.CIR-15-0210","volume":"4","author":"A Ribas","year":"2016","unstructured":"Ribas A, Shin DS, Zaretsky J, Frederiksen J, Cornish A, Avramis E, Seja E, Kivork C, Siebert J, Kaplan-Lefko P, Wang X, Chmielowski B, Glaspy JA, Tumeh PC, Chodon T, pe'er D, comin-anduix b (2016) pd-1 blockade expands intratumoral memory T cells. Cancer Immunol Res 4(3):194\u2013203. https:\/\/doi.org\/10.1158\/2326-6066.CIR-15-0210","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"3517_CR39","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/ni1144","volume":"6","author":"JR Sedy","year":"2005","unstructured":"Sedy JR, Gavrieli M, Potter KG, Hurchla MA, Lindsley RC, Hildner K, Scheu S, Pfeffer K, Ware CF, Murphy TL, Murphy KM (2005) B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat Immunol 6(1):90\u201398. https:\/\/doi.org\/10.1038\/ni1144","journal-title":"Nat Immunol"},{"issue":"8","key":"3517_CR40","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41577-018-0020-8","volume":"18","author":"G Gaud","year":"2018","unstructured":"Gaud G, Lesourne R, Love PE (2018) Regulatory mechanisms in T cell receptor signalling. Nat Rev Immunol 18(8):485\u2013497. https:\/\/doi.org\/10.1038\/s41577-018-0020-8","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"3517_CR41","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/S0167-5699(00)01749-7","volume":"21","author":"A Altman","year":"2000","unstructured":"Altman A, Isakov N, Baier G (2000) Protein kinase Ctheta: a new essential superstar on the T cell stage. Immunol Today 21(11):567\u2013573","journal-title":"Immunol Today"},{"issue":"7","key":"3517_CR42","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1073\/pnas.060028097","volume":"97","author":"N Coudronniere","year":"2000","unstructured":"Coudronniere N, Villalba M, Englund N, Altman A (2000) NF-kappa B activation induced by T cell receptor\/CD28 costimulation is mediated by protein kinase C-theta. Proc Natl Acad Sci U S A 97(7):3394\u20133399. https:\/\/doi.org\/10.1073\/pnas.060028097","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"3517_CR43","doi-asserted-by":"publisher","first-page":"4475","DOI":"10.4049\/jimmunol.174.8.4475","volume":"174","author":"CR Li","year":"2005","unstructured":"Li CR, Berg LJ (2005) Itk is not essential for CD28 signaling in naive T cells. J Immunol 174(8):4475\u20134479. https:\/\/doi.org\/10.4049\/jimmunol.174.8.4475","journal-title":"J Immunol"},{"issue":"12","key":"3517_CR44","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1093\/intimm\/dxn108","volume":"20","author":"K Takeda","year":"2008","unstructured":"Takeda K, Harada Y, Watanabe R, Inutake Y, Ogawa S, Onuki K, Kagaya S, Tanabe K, Kishimoto H, Abe R (2008) CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2\/Gads axis. Int Immunol 20(12):1507\u20131515. https:\/\/doi.org\/10.1093\/intimm\/dxn108","journal-title":"Int Immunol"},{"issue":"4","key":"3517_CR45","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/eji.200636542","volume":"37","author":"P Kropf","year":"2007","unstructured":"Kropf P, Baud D, Marshall SE, Munder M, Mosley A, Fuentes JM, Bangham CR, Taylor GP, Herath S, Choi BS, Soler G, Teoh T, Modolell M, Muller I (2007) Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy. Eur J Immunol 37(4):935\u2013945. https:\/\/doi.org\/10.1002\/eji.200636542","journal-title":"Eur J Immunol"},{"issue":"4","key":"3517_CR46","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1182\/blood-2006-06-031856","volume":"109","author":"PC Rodriguez","year":"2007","unstructured":"Rodriguez PC, Quiceno DG, Ochoa AC (2007) l-arginine availability regulates T lymphocyte cell-cycle progression. Blood 109(4):1568\u20131573. https:\/\/doi.org\/10.1182\/blood-2006-06-031856","journal-title":"Blood"},{"issue":"9","key":"3517_CR47","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.4049\/jimmunol.1001224","volume":"185","author":"PC Rodriguez","year":"2010","unstructured":"Rodriguez PC, Hernandez CP, Morrow K, Sierra R, Zabaleta J, Wyczechowska DD, Ochoa AC (2010) l-arginine deprivation regulates cyclin D3 mRNA stability in human T cells by controlling HuR expression. J Immunol 185(9):5198\u20135204. https:\/\/doi.org\/10.4049\/jimmunol.1001224","journal-title":"J Immunol"},{"issue":"8","key":"3517_CR48","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1084\/jem.20042028","volume":"201","author":"V Bronte","year":"2005","unstructured":"Bronte V, Kasic T, Gri G, Gallana K, Borsellino G, Marigo I, Battistini L, Iafrate M, Prayer-Galetti T, Pagano F, Viola A (2005) Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers. J Exp Med 201(8):1257\u20131268. https:\/\/doi.org\/10.1084\/jem.20042028","journal-title":"J Exp Med"},{"issue":"30","key":"3517_CR49","doi-asserted-by":"publisher","first-page":"47221","DOI":"10.18632\/oncotarget.9722","volume":"7","author":"H Costa","year":"2016","unstructured":"Costa H, Xu X, Overbeek G, Vasaikar S, Patro CP, Kostopoulou ON, Jung M, Shafi G, Ananthaseshan S, Tsipras G, Davoudi B, Mohammad AA, Lam H, Straat K, Wilhelmi V, Shang M, Tegner J, Tong JC, Wong KT, Soderberg-Naucler C, Yaiw KC (2016) Human cytomegalovirus may promote tumour progression by upregulating arginase-2. Oncotarget 7(30):47221\u201347231. https:\/\/doi.org\/10.18632\/oncotarget.9722","journal-title":"Oncotarget"},{"issue":"1","key":"3517_CR50","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13045-019-0770-1","volume":"12","author":"T Liu","year":"2019","unstructured":"Liu T, Han C, Wang S, Fang P, Ma Z, Xu L, Yin R (2019) Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy. J Hematol Oncol 12(1):86. https:\/\/doi.org\/10.1186\/s13045-019-0770-1","journal-title":"J Hematol Oncol"},{"key":"3517_CR51","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.132975","author":"AA Marti-i-Lindez","year":"2019","unstructured":"Marti-i-Lindez AA, Dunand-Sauthier I, Conti M, Gobet F, Nunez N, Hannich JT, Riezman H, Geiger R, Piersigilli A, Hahn K, Lemeille S, Becher B, De Smedt T, Hugues S, Reith W (2019) Mitochondrial arginase-2 is a cellautonomous regulator of CD8+ T cell function and antitumor efficacy. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.132975","journal-title":"JCI Insight"},{"issue":"suppl_11","key":"3517_CR52","doi-asserted-by":"publisher","first-page":"mdx711.052","DOI":"10.1093\/annonc\/mdx711.052","volume":"28","author":"MM Grzybowski","year":"2017","unstructured":"Grzybowski MM, Sta\u0144czak PS, P\u0119czkowicz-Szyszka J, Wolska P, Zdziarska AM, Mazurkiewicz M, Brzezi\u0144ska J, Blaszczyk R, Go\u0142\u0119biowski A, Dobrza\u0144ski P, Dzwonek K (2017) 71PNovel dual arginase 1\/2 inhibitor OATD-02 (OAT-1746) improves the efficacy of immune checkpoint inhibitors. Ann Oncol 28(suppl_11):mdx711.052. https:\/\/doi.org\/10.1093\/annonc\/mdx711.052","journal-title":"Ann Oncol"},{"issue":"2","key":"3517_CR53","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1080\/15384047.2016.1276136","volume":"18","author":"X He","year":"2017","unstructured":"He X, Lin H, Yuan L, Li B (2017) Combination therapy with l-arginine and alpha-PD-L1 antibody boosts immune response against osteosarcoma in immunocompetent mice. Cancer Biol Ther 18(2):94\u2013100. https:\/\/doi.org\/10.1080\/15384047.2016.1276136","journal-title":"Cancer Biol Ther"},{"issue":"5","key":"3517_CR54","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.4049\/jimmunol.176.5.2902","volume":"176","author":"F Vianello","year":"2006","unstructured":"Vianello F, Papeta N, Chen T, Kraft P, White N, Hart WK, Kircher MF, Swart E, Rhee S, Palu G, Irimia D, Toner M, Weissleder R, Poznansky MC (2006) Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1\/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control. J Immunol 176(5):2902\u20132914. https:\/\/doi.org\/10.4049\/jimmunol.176.5.2902","journal-title":"J Immunol"},{"key":"3517_CR55","doi-asserted-by":"publisher","first-page":"10204","DOI":"10.1038\/ncomms10204","volume":"6","author":"J Albrengues","year":"2015","unstructured":"Albrengues J, Bertero T, Grasset E, Bonan S, Maiel M, Bourget I, Philippe C, Herraiz Serrano C, Benamar S, Croce O, Sanz-Moreno V, Meneguzzi G, Feral CC, Cristofari G, Gaggioli C (2015) Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts. Nat Commun 6:10204. https:\/\/doi.org\/10.1038\/ncomms10204","journal-title":"Nat Commun"},{"issue":"23","key":"3517_CR56","doi-asserted-by":"publisher","first-page":"9900","DOI":"10.1158\/0008-5472.CAN-08-1319","volume":"68","author":"L Jiang","year":"2008","unstructured":"Jiang L, Gonda TA, Gamble MV, Salas M, Seshan V, Tu S, Twaddell WS, Hegyi P, Lazar G, Steele I, Varro A, Wang TC, Tycko B (2008) Global hypomethylation of genomic DNA in cancer-associated myofibroblasts. Cancer Res 68(23):9900\u20139908. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-1319","journal-title":"Cancer Res"},{"issue":"1","key":"3517_CR57","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/ol.2016.5451","volume":"13","author":"H Du","year":"2017","unstructured":"Du H, Che G (2017) Genetic alterations and epigenetic alterations of cancer-associated fibroblasts. Oncol Lett 13(1):3\u201312. https:\/\/doi.org\/10.3892\/ol.2016.5451","journal-title":"Oncol Lett"},{"issue":"12","key":"3517_CR58","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/carcin\/bgv146","volume":"36","author":"M Vizoso","year":"2015","unstructured":"Vizoso M, Puig M, Carmona FJ, Maqueda M, Velasquez A, Gomez A, Labernadie A, Lugo R, Gabasa M, Rigat-Brugarolas LG, Trepat X, Ramirez J, Moran S, Vidal E, Reguart N, Perera A, Esteller M, Alcaraz J (2015) Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts. Carcinogenesis 36(12):1453\u20131463. https:\/\/doi.org\/10.1093\/carcin\/bgv146","journal-title":"Carcinogenesis"},{"key":"3517_CR59","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.029447","author":"VS LeBleu","year":"2018","unstructured":"LeBleu VS, Kalluri R (2018) A peek into cancer-associated fibroblasts: origins, functions and translational impact. Dis Model Mech. https:\/\/doi.org\/10.1242\/dmm.029447","journal-title":"Dis Model Mech"},{"issue":"6","key":"3517_CR60","first-page":"696","volume":"68","author":"L Ronnov-Jessen","year":"1993","unstructured":"Ronnov-Jessen L, Petersen OW (1993) Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab Invest 68(6):696\u2013707","journal-title":"Lab Invest"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-020-03517-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-020-03517-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-020-03517-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T07:30:19Z","timestamp":1696059019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-020-03517-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,23]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["3517"],"URL":"https:\/\/doi.org\/10.1007\/s00018-020-03517-8","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,23]]},"assertion":[{"value":"14 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}